Original Article
Mesenteric Inflammatory Myofibroblastic Tumor: Mri and Ct Imaging Correlated to Anatomical Pathology
Authors:
Dr Th. Kirchgesner ,
M.D., Dpt of Radiology, Cliniques Universitaires Saint-Luc, Brussels, Belgium, BE
E. Danse,
Dpt of Radiology, Cliniques Universitaires Saint-Luc, Brussels, Belgium, BE
Ch. Sempoux,
Dpt of Anatomical pathology, Cliniques
Universitaires Saint-Luc, Brussels, Belgium, BE
L. Annet,
Dpt of Radiology, Cliniques Universitaires Saint-Luc, Brussels, Belgium, BE
Ch. Anca Dragean,
Dpt of Radiology, Cliniques Universitaires Saint-Luc, Brussels, Belgium, BE
P. Trefois,
Dpt of Radiology, Cliniques Universitaires Saint-Luc, Brussels, Belgium, BE
N. Abbes Orabi,
Dpt of Colorectal Surgery, Cliniques
Universitaires Saint-Luc, Brussels, Belgium, BE
A. Kartheuser
Dpt of Colorectal Surgery, Cliniques
Universitaires Saint-Luc, Brussels, Belgium., BE
Abstract
Inflammatory myofibroblastic tumor (IMT) is a rare tumor, classified by WHO of intermediate biological potential with tendency for local recurrence and small risk for distant metastasis. Histologically IMT is a mixture of inflammatory cells and myofibroblastic spindle cells proliferation. To our knowledge there is no MRI description of mesenteric IMT in the literature. We would like to emphasize the correlation between medical imaging and anatomical pathology based on our experience of a mesenteric IMT in a 28-year-old patient.
How to Cite:
Kirchgesner DT, Danse E, Sempoux C, Annet L, Dragean CA, Trefois P, et al.. Mesenteric Inflammatory Myofibroblastic Tumor: Mri and Ct Imaging Correlated to Anatomical Pathology. JBR-BTR. 2014;97(5):301–2. DOI: http://doi.org/10.5334/jbr-btr.1335
Published on
01 Sep 2014.
Peer Reviewed
Downloads
